Kangying Redberry

BiotechnologySeries AZhongshan, Chinaky-rubyberries.com

Latest round

Series A

Last raised

Jun 2024

Total raised

Undisclosed

Investors

1

About Kangying Redberry

, Ltd. focuses on developing enzyme-based solutions. Kangying Redberry specializes in biocatalysis, utilizing enzyme technology to provide solutions that tackle industrial challenges. Their enzyme products enhance efficiency in sectors such as food production, pharmaceuticals, and renewable energy, helping clients achieve better yields and reduced processing times. Kangying Redberry generates revenue through direct sales of enzyme products primarily to clients in the food and beverage sector and pharmaceutical companies. They operate on a B2B model, offering tailored enzyme solutions, with potential pricing agreements that include bulk discounts. Their flagship products are designed to address specific industry needs, contributing significantly to their revenue streams.

Who invested in Kangying Redberry

1 investor across 1 round

See all investors in Kangying Redberry

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 5, 2024

    Amount

    Undisclosed

    Investors

    Locked

Questions about Kangying Redberry

Who invested in Kangying Redberry?

Kangying Redberry has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Kangying Redberry raised?

Kangying Redberry has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Kangying Redberry last raise money?

Kangying Redberry's most recent round on record is a Series A, in Jun 2024.

What does Kangying Redberry do?

Kangying Redberry is a biotechnology company.

Where is Kangying Redberry headquartered?

Kangying Redberry is headquartered in Zhongshan, China.

Which VCs invest in companies like Kangying Redberry?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Kangying Redberry's stage. Their profiles are linked below.

Raising like Kangying Redberry? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.